Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
I put GPT-5.5 through a 10-round test: It scored 93/100, losing points only for exuberance ...
David DeSanto is Chief Executive Officer at Anaconda, where he leads the company’s mission to empower the world’s data science and AI communities through open-source innovation and secure enterprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results